Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1404 Views
-
Last post by frodo
-
- 0 Replies
- 1042 Views
-
Last post by frodo
-
- 0 Replies
- 2797 Views
-
Last post by NHE
-
- 0 Replies
- 1362 Views
-
Last post by frodo
-
- 0 Replies
- 1403 Views
-
Last post by frodo
-
- 0 Replies
- 1328 Views
-
Last post by frodo
-
- 0 Replies
- 1718 Views
-
Last post by NHE
-
- 0 Replies
- 633 Views
-
Last post by NHE
-
- 1 Replies
- 3331 Views
-
Last post by Tif